STUDY OF A RIBONUCLEASE AND ITS INHIBITOR FROM BACILLUS AMYLOLIQUEFACIENS
STUDY OF A RIBONUCLEASE AND ITS INHIBITOR FROM BACILLUS AMYLOLIQUEFACIENS
批准号:
3839583
负责人:
R W HARTLEY
金额:
$0.0万
依托单位国家:
美国
项目类别:
财政年份:
--
资助国家:
美国
项目状态:
未结题
起止时间:
至
关键词:
Bacillus Escherichia coli X ray crystallography bacterial genetics bacterial proteins chemical kinetics chemical stability enzyme activity enzyme model enzyme structure enzyme substrate esterase inhibitor gene expression gene induction /repression hydrolysis intermolecular interaction lethal genes molecular cloning mutant nuclear magnetic resonance spectroscopy nucleic acid probes nucleic acid sequence pancreatic ribonuclease plasmids protein biosynthesis protein folding protein sequence recombinant DNA transfection /expression vector
中文摘要
芽孢杆菌的胞外核糖核酸酶Barnase
Amyloliquefaciens及其胞内抑制物Barstar被用作
蛋白质折叠和蛋白质-蛋白质研究的模型系统
互动。Barnase是核糖核酸酶的同源基团之一
存在于原核生物和真核生物中。
重组DNA技术的应用主要有三个目标:(1)
促进野生型和突变蛋白的生产;(2)检测
基因的结构和控制序列;以及(3)使特定的
序列的变化,以测试折叠理论和探索藤本酶-
巴斯塔尔互动。
克隆的野生型barnase基因的致死作用可被
Barstar基因在同一质粒上的表达。大肠杆菌质粒
已经为这两种蛋白质设计了载体,现在两种蛋白质都可以获得
基本上纯净量为100毫克。DNA和氨基酸序列以及x-
两者的射线结构以及核磁共振溶液结构都是已知的
巴纳萨斯。一种合成的荧光基质已被用于研究
并考察其动力学和稳定性。
天然蛋白和突变蛋白的Barnase-Barstar相互作用。接近于
每种蛋白质都产生了数百个定向突变。其中一些
这些都是针对特定问题的,但大多数都是对
蛋白质表面设计用于定位其相互作用区域和残基
这两个人都被确认参与其中。的两个半胱氨酸残基
Barstar都可以被ALA取代而不失去活性(体外或
在体内,但随着键的强度有所降低)或收益率将
极大地简化了未来对Barstar折叠的研究。这样的替换
其中一个或两个半胱氨酸残基使巴司塔的稳定性仅降低到
在硫醇或DTT存在下测量的野生型。
已经发展了几种测量相对和绝对的方法
不同组合下Barnase和Barstar之间的结合强度
野生型和突变型蛋白质。对于野生型蛋白质来说
解离系数在10到-13的数量级。
最近的研究,在其他地方,在这些工作中,barnase基因连接到一个
以杀死该启动子所在的组织
表达(首先在植物中产生雄性不育)
引起了人们对它在发展研究中的可能应用的相当大的兴趣
也是各种抗病毒策略的关键。
英文摘要
Two proteins, barnase, the extracellular ribonuclease of Bacillus
amyloliquefaciens, and barstar, its intracellular inhibitor, are used as a
model system for the study of protein folding and protein-protein
interactions. Barnase is one of an homologous group of ribonuclease
occurring in both prokaryotes and eukaryotes.
Recombinant DNA techniques are being applied with three major aims: (1) to
facilitate production of wild type and mutant proteins; (2) to examine the
structural and control sequences of the genes; and (3) to make specific
changes in the sequences to test theories of folding and probe the barnase-
barstar interaction.
The lethal effect of the cloned wild type barnase gene can be repressed by
expression of the barstar gene on the same plasmid. E. coli plasmid
vectors have been devised for both proteins and both can now be obtained
essentially pure in 100 mg quantities. DNA and amino acid sequences and x-
ray structures of both are known as well as the NMR solution structure of
barnase. A synthetic fluorescent substrate has been used to study
hydrolysis kinetics and to look at the kinetics and stability of the
barnase-barstar interaction for native and mutant proteins. Close to a
hundred directed mutations in each protein have been produced. Some of
these were aimed at specific questions but most are part of a survey of the
protein surfaces designed to locate their areas of interaction and residues
on both have been identified as being so involved. The two Cys residues of
barstar can both be replaced by Ala without loss of activity (in vitro or
in vivo, but with some reduction in the strength of the bond) or yield will
greatly simplify future studies of barstar folding. Such replacement of
either or both of the Cys residues reduces the stability of barstar only to
that of the wild-type measured in the presence of mercaptoethanol or DTT.
Several methods have been developed for measuring the relative and absolute
strength of the bond between barnase and barstar for various combinations
of wild-type and mutant proteins. For the wild-type proteins the
dissociation coefficient is on the order of 10 to the -13.
Recent work, elsewhere, in which the barnase gene was attached to a
eukaryotic promoter in order to kill the tissue in which that promoter is
expressed (in the first instance to produce male sterility in plants) has
aroused considerable interest in its possible use in developmental studies
and is the key to a variety of anti-viral strategies.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
STUDY OF A RIBONUCLEASE AND ITS INHIBITOR FROM BACILLUS AMYLOLIQUEFACIENS
-
批准号:5201904
-
项目类别:
-
资助金额:$0.0万
-
财政年份:--
-
负责人:R W HARTLEY
-
依托单位:
RIBONUCLEASE AND ITS INHIBITOR FROM BACILLUS AMYLOLIQUEFACIENS
-
批准号:3875541
-
项目类别:
-
资助金额:$0.0万
-
财政年份:--
-
负责人:R W HARTLEY
-
依托单位:
STUDY OF A RIBONUCLEASE AND ITS INHIBITOR FROM BACILLUS AMYLOLIQUEFACIENS
-
批准号:6161886
-
项目类别:
-
资助金额:$0.0万
-
财政年份:--
-
负责人:R W HARTLEY
-
依托单位:
RIBONUCLEASE AND ITS INHIBITOR FROM BACILLUS AMYLOLIQUENFACIENS
-
批准号:3940232
-
项目类别:
-
资助金额:$0.0万
-
财政年份:--
-
负责人:R W HARTLEY
-
依托单位:
RIBONUCLEASE AND ITS INHIBITOR FROM BACILLUS AMYLOLIQUENFACIENS
-
批准号:4689017
-
项目类别:
-
资助金额:$0.0万
-
财政年份:--
-
负责人:R W HARTLEY
-
依托单位:
STUDY OF A RIBONUCLEASE AND ITS INHIBITOR FROM BACILLUS AMYLOLIQUEFACIENS
-
批准号:2572771
-
项目类别:
-
资助金额:$0.0万
-
财政年份:--
-
负责人:R W HARTLEY
-
依托单位:
RIBONUCLEASE AND ITS INHIBITOR FROM BACILLUS AMYLOLIQUENFACIENS
-
批准号:3917361
-
项目类别:
-
资助金额:$0.0万
-
财政年份:--
-
负责人:R W HARTLEY
-
依托单位:
RIBONUCLEASE AND ITS INHIBITOR FROM BACILLUS AMYLOLIQUENFACIENS
-
批准号:3964011
-
项目类别:
-
资助金额:$0.0万
-
财政年份:--
-
负责人:R W HARTLEY
-
依托单位:
STUDY OF A RIBONUCLEASE AND ITS INHIBITOR FROM BACILLUS AMYLOLIQUEFACIENS
-
批准号:3753948
-
项目类别:
-
资助金额:$0.0万
-
财政年份:--
-
负责人:R W HARTLEY
-
依托单位:
STUDY OF A RIBONUCLEASE AND ITS INHIBITOR FROM BACILLUS AMYLOLIQUEFACIENS
-
批准号:3776059
-
项目类别:
-
资助金额:$0.0万
-
财政年份:--
-
负责人:R W HARTLEY
-
依托单位:
RIBONUCLEASE AND ITS INHIBITOR FROM BACILLUS AMYLOLIQUEFACIENS
-
批准号:3854534
-
项目类别:
-
资助金额:$0.0万
-
财政年份:--
-
负责人:R W HARTLEY
-
依托单位:
国内基金
海外基金
登录
查看更多内容
asr基因调控酸诱导的Escherichia coli O157:H7形成VBNC状态的机制研究
-
批准号:32302245
-
项目类别:青年科学基金项目
-
资助金额:30.00万元
-
批准年份:2023
-
负责人:潘寒姁
-
依托单位:
小肠中Escherichia coli分泌细菌毒素诱导肠屏障损伤及细菌易位在炎症性肠病中的机制研究
-
批准号:82371775
-
项目类别:面上项目
-
资助金额:46万元
-
批准年份:2023
-
负责人:朱慧媛
-
依托单位:
基于Escherichia coli O157:H7亚致死态细胞探究超高压与原儿茶酸协同杀菌机制
-
批准号:31871817
-
项目类别:面上项目
-
资助金额:60.0万元
-
批准年份:2018
-
负责人:孙爱东
-
依托单位:
肠肝轴:从临床患者分离的肠道致病菌株Escherichia coli NF73-1对非酒精性脂肪性肝病的作用及机制研究
-
批准号:81873549
-
项目类别:面上项目
-
资助金额:57.0万元
-
批准年份:2018
-
负责人:刘玉兰
-
依托单位:
高压二氧化碳诱导Escherichia coli O157:H7形成VBNC状态的分子机制
-
批准号:31571933
-
项目类别:面上项目
-
资助金额:57.0万元
-
批准年份:2015
-
负责人:廖小军
-
依托单位:
超高压诱导牛肉中Escherichia coli O157:H7亚致死损伤及其修复研究
-
批准号:31371861
-
项目类别:面上项目
-
资助金额:15.0万元
-
批准年份:2013
-
负责人:江芸
-
依托单位:
高压二氧化碳诱导Escherichia coli O157:H7形成VBNC状态的机制
-
批准号:31371845
-
项目类别:面上项目
-
资助金额:15.0万元
-
批准年份:2013
-
负责人:廖小军
-
依托单位:
高密度二氧化碳致死Escherichia coli的相关蛋白质确证及其结构变化研究
-
批准号:31171774
-
项目类别:面上项目
-
资助金额:66.0万元
-
批准年份:2011
-
负责人:张德权
-
依托单位: